SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors await top-line Phase 2 data for its ABCL635 menopause treatment, a binary catalyst that the community believes will validate the company's AI-driven drug discovery platform. While the stock has seen significant volatility amid rumors and sector-wide biotech shifts, discussions are dominated by institutional partnerships and high conviction in long-term platform value despite ongoing debates over short interest and historical share performance.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to the joint launch of a mass-production-ready intelligent driving platform with Axera Semiconductor, fueling community excitement over growing QNX integrations in automotive and robotics sectors. Investors are actively discussing the stock's long-term potential in the software-defined vehicle market while monitoring institutional accumulation and upcoming investor events for further catalysts.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors eagerly await topline results from the Phase 3 IZAR-1 trial, with community discussions polarized between anticipation of best-in-class efficacy data and frustration over the delayed release. Market participants are closely watching for a potential data drop alongside upcoming earnings, while debates continue regarding the stock's valuation, potential acquisition interest, and the impact of the company's clinical timeline communication.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's strategic pivot toward AI infrastructure following its acquisition of Northern Data, with the community closely monitoring upcoming earnings and formal revenue guidance. Market participants are actively debating the potential for a short squeeze, citing high short interest and institutional backing from Tether, while others remain focused on the company's long-term ability to monetize its newly acquired data centers and compute capacity.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is surging due to significant institutional accumulation and a string of successful defense and commercial contract wins, including recent deployments at NFL venues and major military orders. The community is actively debating the company's growth as a defense conglomerate, with many investors anticipating that upcoming earnings will catalyze a major short squeeze and push the stock toward significantly higher valuation levels.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is currently capturing significant investor attention as the company moves to unlock value through a planned IPO of its North American assets and a new $3B share buyback program. Community sentiment remains split, with some traders optimistic about long-term fundamental support from rising gold prices and copper growth, while others closely watch the impact of operational costs and production targets on bottom-line profitability.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is experiencing intense volatility and heavy short-selling volume as investors debate whether its AI-integrated work platform will face long-term disruption from emerging AI agents. While some in the community see the stock as a deeply undervalued play with a strong cash position, others remain skeptical about the sustainability of its business model in an AI-native landscape.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is facing increased volatility and bearish sentiment following reports that it is testing Chinese-made memory chips for its devices, fueling community debates regarding potential supply chain shifts and the competitive pressure of rising component costs. While some retail investors view the recent price action as a buying opportunity, others are actively debating whether these developments indicate long-term margin pressure or merely a strategic publicity move to manage hardware pricing.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is trending as investors focus on its strengthening position in the AI infrastructure and high-performance computing space, highlighted by recent strategic collaborations in quantum computing and strong enterprise demand. Community discussions are centered on the stock's consolidation patterns near key resistance levels and its perceived valuation gap relative to broader sector peers.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following FDA approval for Auvelity as a treatment for agitation in Alzheimer's disease, a major catalyst that has prompted analysts to raise peak sales projections to $8 billion. The community remains highly focused on the upcoming Q2 earnings call, with active discussions centering on the companys commercial execution, the successful integration of its expanded sales force, and anticipation of an international partnership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Relmada Therapeutics Joins Russell 2000 Index And Russell 3000 Index

Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company"))), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, todayread more...

Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call

HC Wainwright initiates Relmada Therapeutics (NASDAQ: RLMD) with a Buy rating and $12 target, highlighting its bladder cancer potential.read more...

Transcript: Relmada Therapeutics Q1 2026 Earnings Conference Call

Relmada Therapeutics (NASDAQ:RLMD) Reaches New 1-Year High  - Time to Buy?

Relmada Therapeutics (NASDAQ:RLMD) Reaches New 1-Year High - Should You Buy...

Relmada Therapeutics (RLMD) Projected to Post Quarterly Earnings on Monday

Relmada Therapeutics (NASDAQ:RLMD) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-relmada-therapeutics-inc-stock...

Relmada Therapeutics (NASDAQ:RLMD) Trading Down 4.3% - Here's What Happened

Relmada Therapeutics (NASDAQ:RLMD) Shares Down 4.3% - What's Next...

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Sees Large Increase in Short Interest

Relmada Therapeutics, Inc. (NASDAQ:RLMD - Get Free Report) was the target of a large increase in short interest in March. As of March 31st, there was short interest totaling 6,042,204 shares, an increase of 61.9% from the March 15th total of 3,731,201 shares. Currently, 7.3% of the company's stock...

Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?

The mean of analysts' price targets for Relmada Therapeutics (RLMD) points to a 75.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Relmada Therapeutics (NASDAQ:RLMD) Hits New 12-Month High - Should You Buy?

Relmada Therapeutics (NASDAQ:RLMD) Sets New 12-Month High - Here's What Happened...

Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics

Small drug stocks like Indivior gain traction as biotech recovery strengthens, fueled by innovation, M&A activity, and promising pipeline developments.

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.

Relmada Therapeutics Inc

RLMD Stock Soars Pre-Market: Phase 2 Bladder Cancer Trial Data Impresses Investors

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

RLMDRelmada Therapeutics Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest RLMD News